About 1 result found for searched term "2092925-89-6" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M45361 | Palazestrant | Estrogen Receptor |
| OP-1250 | ||
| Palazestrant is a novel, orally active, estrogen receptor antagonist and selective estrogen receptor degrader. It can be used in studies related to ER+/HER2+ breast cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
